Küst, Jutta, Disko, Andreas, Calendo, Luigi Riccardo et al. · Praxis · 2023
Quick Summary
This guideline explains how to help people recover from post-COVID illness, which can cause lasting fatigue and memory problems that make it hard to work or manage daily life. Since there is no cure yet, treatment focuses on rehabilitation that is tailored to each patient's symptoms and goals, with special attention to gradually rebuilding activity while watching for post-exertional malaise—a worsening of symptoms after physical or mental effort. The approach involves multiple healthcare professionals working together to adjust the workload based on how the patient is doing over time.
Why It Matters
This guideline is directly relevant to ME/CFS because post-COVID conditions share significant phenotypic overlap with ME/CFS, particularly regarding exertional intolerance and post-exertional malaise. The emphasis on cautious, individualized activity management and avoidance of harm from overexertion provides evidence-informed principles applicable to both conditions. Recognition that fatigue and cognitive dysfunction are central rehabilitation targets validates these as primary outcome domains in ME/CFS research and care.
Observed Findings
Fatigue and cognitive impairment are among the most common post-COVID symptoms affecting functional capacity.
Post-exertional malaise represents a critical clinical feature requiring special monitoring during rehabilitation.
The course of post-COVID disease is characteristically fluctuating, necessitating periodic reevaluation.
Many patients experience major difficulty resuming previous daily routines and occupational roles.
Interprofessional, integrated rehabilitation approaches are recommended given the multi-system nature of post-COVID.
Inferred Conclusions
Fatigue management should be a central component of post-COVID rehabilitation programs.
Activity should be increased very gradually with close attention to post-exertional malaise as a warning sign.
Workload should be periodically adjusted downward if symptoms fluctuate or worsen, rather than following linear progression.
Rehabilitation effectiveness depends on alignment between objective clinical findings and patient-defined functional goals.
Remaining Questions
What objective biomarkers or functional tests best predict safe activity progression in post-COVID patients?
What This Study Does Not Prove
This guideline does not establish the etiology of post-COVID disease or prove the efficacy of specific rehabilitation interventions through randomized trials. It does not differentiate post-COVID from ME/CFS or other fatigue-related conditions, nor does it provide quantitative outcome data on recovery rates. The lack of causal therapeutic approaches acknowledged in the abstract means no proven disease-modifying treatments are documented.
How do specific rehabilitation protocols (graded exercise versus pacing versus other approaches) compare in outcomes for post-COVID versus ME/CFS populations?
What mechanisms explain the fluctuating course of symptoms, and can predictors of fluctuation inform rehabilitation timing?
What is the optimal frequency and method for periodic reassessment and workload adjustment during rehabilitation?